RE:iA Capital - cantechletter.comWhat excites me is that invitro and other fertility therapies are now being covered by private health care plans. Insurance companies are offering coverage for this type of therapiy and and companies are adding it to their list of employee benefits. This will continue to expand into more and more benefit plans.
This is huge for this space. I have no idea why HTL is still under $2. It is a steal of a deal under $2 in my opinion.